Company: ZDAN
Filing Date: 2025-07-28
Form Type: F-1/A
Source: 0001683168-25-005450
Chunk: 267

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-07-28
Form: F-1/A
Chunk 267
---
)(D).
The sole demand registration right provided will not be greater than five years from the commencement of sales of the public offering
in compliance with FINRA Rule 5110(g)(8)(C). The warrants will have anti-dilution terms that are consistent with FINRA Rule 5110(g)(8)(E)
and (F). The Company will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other
than underwriting commissions incurred and payable by the holders.

The exercise price and number
of Ordinary Shares issuable upon exercise of the Underwriter’s Warrants may be adjusted in certain circumstances, including in
the event of a stock dividend, extraordinary cash dividend, or our recapitalization, reorganization, merger, or consolidation.

Right of First Refusal

We have granted the Underwriter
a right of first refusal (“ROFR”) to act as lead or joint investment banker, lead or joint bookrunner and/or lead or joint
placement agent, for each and every future public and private equity and debt offering which we undertake (each, a “Subject Transaction”).
The ROFR expires 24 months after the closing of this offering or the termination of the engagement letter entered into by and between
the Company and the Underwriter on February 20, 2023. The ROFR shall be contingent upon the written agreement by the Underwriter to participate
in any Subject Transaction upon the terms and conditions which should contain reasonable and customary fees for transactions of similar
size and nature; provided, however, that in no event shall the Underwriter’s fees be less than the amount in this offering.

Lock-Up Agreements

We have agreed, subject
to certain exceptions, not to, without the prior written consent of the Underwriter, directly or indirectly, for a period of 180 days
after the date of the underwriting agreement: sell, encumber, grant any option for the sale of, or otherwise dispose of, except in this
offering, any of our Ordinary Shares, without the prior written consent of the Underwriter.

| 165 |

Furthermore, each of our
directors and executive officers, and our existing beneficial owners of 5% or more of our outstanding Ordinary Shares will enter into
a similar lock-up agreement for a period of 180 days from the SEC’s declaration of effectiveness of our registration statement
on Form F-1, of which this prospectus forms a part, subject to certain exceptions, with respect to our Ordinary Shares and securities